Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

被引：0
|
作者：
Anders, Hans J. [1 ]
Rovin, Brad H. [2 ]
Zhao, Ming Hui [3 ]
Malvar, Ana [4 ]
Hiromura, Keiju [5 ]
Jones-Leone, Angela R. [6 ]
Gonzalez-Rivera, Tania [6 ]
Gilbride, Jennifer A. [7 ]
Madan, Anuradha [6 ]
Green, Yulia [8 ]
Roth, David A. [6 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Peking Univ First Hosp, Beijing, Peoples R China
[4] Org Med Invest, Buenos Aires, DF, Argentina
[5] Gunma Univ, Grad Sch Med, Dept Nephrol & Rheumatol, Maebashi, Gumma, Japan
[6] GlaxoSmithKline, Collegeville, PA USA
[7] GlaxoSmithKline, Stevenage, Herts, England
[8] GlaxoSmithKline, Brentford, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-OR32
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [31] Increased tyrosine nitration in the renal tissue of patients with active lupus nephritis.
    Kajiyama, H
    Terai, C
    Nakagawa, M
    Koseki, Y
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S297 - S297
  • [32] Renal Activity Index for Lupus Nephritis Distinguishes Active Renal Disease Among Childhood Systemic Lupus Erythematosus Patients
    Aljaberi, Najla
    Mathur, Arjun
    Jose, Steffy
    Hennard, Theresa
    Merritt, Angela
    Ma, Qing
    Rose, James
    Sahay, Rashmi
    Liu, Chunyan
    Wenderfer, Scott
    Brunner, Hermine I.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [33] Association of regulatory T cells with renal outcomes in patients with proliferative lupus nephritis
    Wang, Jingjing
    Zhu, Mengyue
    Jiao, Chenfeng
    Xu, Xiaodong
    Xu, Feng
    Liang, Dandan
    Liu, Zhengzhao
    Chen, Yinghua
    Zhang, Haitao
    LUPUS, 2023, 32 (11) : 1237 - 1244
  • [34] Clinical outcomes in lupus nephritis patients treated with belimumab in real-life setting: a retrospective comparative study in China
    Lin, Zishan
    Jiang, Bingjing
    Wang, Wenfeng
    Chen, Caiming
    Wang, Yujia
    Wan, Jianxin
    Xu, Yanfang
    PEERJ, 2024, 12
  • [35] Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
    Gatto, Mariele
    Saccon, Francesca
    Andreoli, Laura
    Bartoloni, Elena
    Benvenuti, Francesco
    Bortoluzzi, Alessandra
    Bozzolo, Enrica
    Brunetta, Enrico
    Canti, Valentina
    Cardinaletti, Paolo
    Ceccarelli, Fulvia
    Ciccia, Francesco
    Conti, Fabrizio
    De Marchi, Ginevra
    de Paulis, Amato
    De Vita, Salvatore
    Emmi, Giacomo
    Faggioli, Paola
    Fasano, Serena
    Fredi, Micaela
    Gabrielli, Armando
    Gasparotto, Michela
    Gerli, Roberto
    Gerosa, Maria
    Govoni, Marcello
    Gremese, Elisa
    Laria, Antonella
    Larosa, Maddalena
    Mosca, Marta
    Orsolini, Giovanni
    Pazzola, Giulia
    Petricca, Luca
    Ramirez, Giuseppe A.
    Regola, Francesca
    Rossi, Francesca W.
    Rossini, Maurizio
    Salvarani, Carlo
    Scarpato, Salvatore
    Tani, Chiara
    Tincani, Angela
    Ubiali, Tania
    Urban, Maria Letizia
    Zen, Margherita
    Doria, Andrea
    Iaccarino, Luca
    JOURNAL OF AUTOIMMUNITY, 2021, 124
  • [36] Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus
    Kan, Hong
    Nagar, Saurabh
    Patel, Jeetvan
    Wallace, Daniel J.
    Molta, Charles
    Chang, David J.
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 610 - 624
  • [37] Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus
    Iaccarino, Luca
    Bettio, Silvano
    Reggia, Rossella
    Zen, Margherita
    Frassi, Micol
    Andreoli, Laura
    Gatto, Mariele
    Piantoni, Silvia
    Nalotto, Linda
    Franceschini, Franco
    Larosa, Maddalena
    Fredi, Micaela
    Punzi, Leonardo
    Tincani, Angela
    Doria, Andrea
    ARTHRITIS CARE & RESEARCH, 2017, 69 (01) : 115 - 123
  • [38] Renal Outcomes and Predictive Analysis of Progression in Newly Diagnosed Multiple Myeloma Patients
    Lalwani, Devansh
    Khan, Hamza
    Nair, Aditya
    Mishra, Dhyey
    Shah, Jash
    Nabar, Leeladhar
    Talati, Shriraj
    Tembhare, Prashant
    Nayak, Lingaraj
    Shetty, Alok
    Rajpal, Sweta
    Chatterjee, Gaurav
    Khan, Ajmat
    Mirgh, Sumeet
    Jindal, Nishant
    Gokarn, Anant
    Punatar, Sachin
    Jain, Hasmukh
    Patkar, Nikhil
    Shetty, Dhanlaxmi
    Subramanian, Papagudi
    Gujral, Sumeet
    Bagal, Bhausaheb
    Sengar, Manju
    Khattry, Navin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S233 - S234
  • [39] Improving outcomes with novel therapies for patients with newly diagnosed renal cell carcinoma
    Speca, JoEllen
    Yenser, Sarah
    Creel, Patricia
    George, Daniel
    CLINICAL GENITOURINARY CANCER, 2006, 5 : S24 - S30
  • [40] A cost-utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand
    Mohara, Adun
    Velasco, Roman Perez
    Praditsitthikorn, Naiyana
    Avihingsanon, Yingyos
    Teerawattananon, Yot
    RHEUMATOLOGY, 2014, 53 (01) : 138 - 144
12345